Furthermore, GLP-1RA, a hypoglycaemic agent, can effectively decrease ectopic abdominal adipose tissue, liver fat deposits, and liver enzymes while increasing insulin sensitivity in obese patients with T2DM [14, 25]. Here, INS is linked to type 2 diabetes mellitus.